Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Molecular and Cellular Neurosciences
|
June 23, 2006
The effects of a dominant connexin32 mutant in myelinating Schwann cells
Linda Jo Bone Jeng, Rita J Balice-Gordon, Albee Messing, et al.
Behavioural Brain Research
|
July 5, 2026
Behavioral characterization of bulbar sensorimotor function in a rat model of Alexander disease
Jared Cullen, John Russell, Cynthia A Kelm-Nelson, et al.
Development (Cambridge, England)
|
June 10, 2005
PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization
Qing Yue, Matthias Groszer, Jose S Gil, et al.
Genesis (New York, N.Y. : 2000)
|
February 22, 2002
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene
Ralf Lesche, Matthias Groszer, Jing Gao, et al.
Journal of Neuroinflammation
|
March 9, 2021
Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes
Michelle M Boyd, Suzanne J Litscher, Laura L Seitz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 11, 2005
Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice
Steven S Scherer, Yi-Tian Xu, Albee Messing, et al.
Plos One
|
September 18, 2015
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
Christine M LaPash Daniels, Elizabeth Paffenroth, Elizabeth V Austin, et al.
Human Molecular Genetics
|
July 15, 2005
Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction
Tracy L Hagemann, Stephen A Gaeta, Mark A Smith, et al.
Annals of Neurology
|
December 12, 2017
Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease
Tracy L Hagemann, Berit Powers, Curt Mazur, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 2, 2022
Anastasis Drives Senescence and Non-Cell Autonomous Neurodegeneration in the Astrogliopathy Alexander Disease
Liqun Wang, Hassan Bukhari, Linghai Kong, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Molecular and Cellular Neurosciences
|
June 23, 2006
The effects of a dominant connexin32 mutant in myelinating Schwann cells
Linda Jo Bone Jeng, Rita J Balice-Gordon, Albee Messing, et al.
Behavioural Brain Research
|
July 5, 2026
Behavioral characterization of bulbar sensorimotor function in a rat model of Alexander disease
Jared Cullen, John Russell, Cynthia A Kelm-Nelson, et al.
Development (Cambridge, England)
|
June 10, 2005
PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization
Qing Yue, Matthias Groszer, Jose S Gil, et al.
Genesis (New York, N.Y. : 2000)
|
February 22, 2002
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene
Ralf Lesche, Matthias Groszer, Jing Gao, et al.
Journal of Neuroinflammation
|
March 9, 2021
Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes
Michelle M Boyd, Suzanne J Litscher, Laura L Seitz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 11, 2005
Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice
Steven S Scherer, Yi-Tian Xu, Albee Messing, et al.
Plos One
|
September 18, 2015
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
Christine M LaPash Daniels, Elizabeth Paffenroth, Elizabeth V Austin, et al.
Human Molecular Genetics
|
July 15, 2005
Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction
Tracy L Hagemann, Stephen A Gaeta, Mark A Smith, et al.
Annals of Neurology
|
December 12, 2017
Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease
Tracy L Hagemann, Berit Powers, Curt Mazur, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 2, 2022
Anastasis Drives Senescence and Non-Cell Autonomous Neurodegeneration in the Astrogliopathy Alexander Disease
Liqun Wang, Hassan Bukhari, Linghai Kong, et al.
Page
of 11